Health Care & Life Sciences » Biotechnology | OncoSil Medical Ltd.

OncoSil Medical Ltd.

OncoSil Medical Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0.02
Market Cap
AUD34.69 M
Shares Outstanding
630.71 M
Public Float
486.16 M

Profile

Address
50 Berry Street
North Sydney New South Wales (NSW) 2060
Australia
Employees -
Website http://www.oncosil.com.au
Updated 07/08/2019
OncoSil Medical Ltd. develops and commercializes neurology services, including those for pancreatic cancer. It is engaged in the development of novel and safer radiation therapy treatments. The company was founded by David McAuliffe on April 14, 2005 and is headquartered in North Sydney, Australia.

Financials

View All
Created with Highcharts 5.0.14OncoSil Medical Ltd.Net Income. Fiscal year is July-June. All values AUD Thousands.6 8646 8642 8792 8794 7684 7687 0167 0168 5398 5392014201520162017201802k4k6k8k10k

Christopher Graham Roberts
Non-Executive Chairman
Roger Aston
Non-Executive Director